News
FDA set to raise bar for clinical trials of CAR-T therapies
The FDA could make it harder for developers of CAR-T therapies to bring them to market by requiring full randomised controlled trials.
News
Lab-in-a-loop specialist Relation attracts Novartis alliance
UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.
News
FDA backs first AI tool for use in trials, targeting MASH
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.
News
ASH: Jaypirca matches Imbruvica in first-line CLL trial
Eli Lilly has revealed the data it hopes will take BTK inhibitor Jaypirca into frontline use for chronic lymphocytic leukaemia.
News
ASH: FDA okays Gamida aplastic anaemia therapy as data drops
The first cell therapy for severe aplastic anaemia – Gamida Cell's Omisirge – has been approved by the FDA.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
